Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed in Recurrent Cervical Cancer
NCT00087113Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Aug 2004
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in Cervical Cancer (CC), sponsored by GOG Foundation. Started Aug 2004; status: completed.
02
Drugs
pemetrexed
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT00087113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00087113.